Vesalius Cardiovascular - Crunchbase Company Profile & Funding

Q: How much funding has Vesalius Cardiovascular raised to date?

Vesalius Cardiovascular has raised obfuscated.

Overview

Vesalius Cardiovascular

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Vesalius Cardiovascular

CB Rank

86980

Vesalius Cardiovascular is a preclinical medical device company in the structural heart space.

Founded

obfuscation

Private

Venture - Series Unknown

Vancouver, British Columbia, Canada

1-10

www.vesaliuscardio.com

Biotechnology

Health Care

Medical Device

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Vincent Ledoux: CEO and Co-Founder
Peter Skarsgard: Co-Founder and Chief Scientific Officer

Details

Legal Name

Vesalius Cardiovascular Inc.

Operating Status

Active

Company Type

For Profit

Founders

Peter Skarsgard, Vincent Ledoux

About the Company

Vesalius Cardiovascular is a Canadian medical device company founded in 2016 in Vancouver, Canada. The company specializes in designing and developing biomedical devices for the treatment of cardiovascular disease, specifically mitral valve regurgitation (MR)

Phone Number

604-559-6162

Contact Email

info@vesaliuscardio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Calla TMVr System

A percutaneous device for treating degenerative mitral regurgitation, utilizing transfemoral delivery to repair the mitral valve without open-heart surgery.

Transfemoral Mitral Valve Repair Solution

Develops a solution for degenerative mitral regurgitation using techniques like annuloplasty and chordal replacement, based on surgical principles but without the need for open surgery.

Research & Development

Vesalius Cardiovascular is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Vesalius Cardiovascular	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
VGH and UBC Hospital Foundation	—	Grant - Vesalius Cardiovascular	—
VGH and UBC Hospital Foundation	—	Grant - Vesalius Cardiovascular	—
VGH and UBC Hospital Foundation	—	Grant - Vesalius Cardiovascular	—
VGH and UBC Hospital Foundation	—	Grant - Vesalius Cardiovascular	—
VGH and UBC Hospital Foundation	—	Grant - Vesalius Cardiovascular	—